Previous Close | 20.56 |
Open | 21.00 |
Bid | 20.20 x 800 |
Ask | 21.14 x 1300 |
Day's Range | 19.98 - 21.26 |
52 Week Range | 11.46 - 40.50 |
Volume | |
Avg. Volume | 1,023,876 |
Market Cap | 1.163B |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.81 |
Earnings Date | Nov 16, 2023 - Nov 20, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 25.90 |
Subscribe to Yahoo Finance Plus to view Fair Value for TWST
SOUTH SAN FRANCISCO, Calif. & SAN RAFAEL, Calif. & BARCELONA, September 27, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and IMIDomics, Inc., a patient-centric drug discovery and development company focused on Immune-Mediated Inflammatory Diseases (IMIDs), today announced a multi-program collaboration whereby Twist will utilize its antigen development capabilities and Libr
Unraveling the Factors That Could Limit the Company's Future Growth
Exploring the Financial Health of Twist Bioscience: An In-Depth Analysis